Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
King Sun Chemical & Pharmaceutical is a China-based chemical and pharmaceutical company focused on the research, development, cooperative production, and commercialization of active pharmaceutical ingredients, pharmaceutical intermediates, and related fine chemicals. The company appears to operate primarily as a supplier and custom manufacturing partner rather than as a therapeutic drug developer with a disclosed clinical pipeline. Publicly available profiles describe capabilities spanning laboratory synthesis, process development, pilot-scale production, and commercial manufacturing, with supporting technical cooperation networks across multiple Chinese manufacturing sites. Its business also extends to electronic chemicals and other fine chemicals, and some sources indicate associated GMP-audited manufacturing partners. Overall, the company is best characterized as a small-molecule pharma chemistry and manufacturing services provider serving B2B customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on King Sun Chemical & Pharmaceutical.